$1.2 Billion Pharmaceutical Gelatin Markets, 2025


Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "Pharmaceutical Gelatin Market by Source (Porcine, Bovine Skin, Bovine Bone, Fish, Poultry), Application (Hard Capsule, Soft Capsule, Tablet, Absorbable Hemostat), Function (Stabilizing, Thickening, Gelling), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Pharmaceutical Gelatin Market is Projected to Reach USD 1.2 Billion by 2025 from USD 1.0 Billion in 2020, at a CAGR of 5.3% during the Forecast Period.

Growth of this market is driven by the versatility of gelatin in pharmaceutical applications. Its superior functional properties make it suitable for medical and biomedical applications. The growth of the market can also be attributed to the rise in chronic illnesses and aging population. However, factors such as the fluctuating availability of raw material and cultural restrictions on the consumption of porcine and bovine-derived gelatin are expected to restrain the growth of this market to a certain extent during the forecast period.

The hard capsules segment holds the highest market share, by application, in the forecast period.

On the basis of application, the pharmaceutical gelatin market is segmented into hard capsules, softgel capsules, tablets, absorbable hemostats & other applications. The hard capsules segment is expected to hold the highest share in the pharmaceutical gelatin market during the forecast period. Growth in this segment is largely driven by the stability, safety, security and efficacy provided by gelatin in hard capsules, and suitability of gelatin hard capsules for immediate-release dosing.

Increasing preference for bovine bone as an alternative to pig meat gelatin in the pharmaceutical industry driving market growth for this segment.

On the basis of source, the pharmaceutical gelatin market is further segmented into porcine, bovine skin, bovine bone, marine & poultry. The bovine bone segment is projected to witness the highest growth in the pharmaceutical gelatin market, by source, during the forecast period. Bovine bone is suitable for use across a range of pharmaceutical applications including hard and softgel capsules, tablets, gelatin sponges, and plasma expanders due to its low Bloom and high viscosity. The high viscosity to Bloom ratio of bovine bone is especially advantageous in the manufacture of softgel capsules. These factors are accelerating the growth of this segment during the forecast period.

By function, the stabilizing agent segment holds the highest market share in the pharmaceutical gelatin market

On the basis of function, the pharmaceutical gelatin market is further segmented into stabilizing agent, thickening agent, gelling agent & other functions. The stabilizing agent segment is expected to hold the highest share in the pharmaceutical gelatin market, by source, during the forecast period. Gelatin has the ability to reduce surface and interfacial tensions, adsorb on to solid surfaces, and enhance the stability of oil-in-water emulsions, moreover, film formation by gelatin can stabilize surface interfaces by forming a film. These effects are utilized in the stabilization of emulsions in pharmaceutical applications and can be attributed to the large market share of this segment during the forecast period.

By type, Type A pharmaceutical gelatin is growing at the fastest rate in the forecast period

On the basis of type, the pharmaceutical gelatin market is further segmented into Type A and Type B. The Type A segment relates mainly to porcine gelatin. The Type A process for porcine gelatin requires shorter time for pre-treatment prior to the extraction of gelatin and minimizes the generation of wastewater. These factors are projected to drive the growth of the Type A segment during the forecast period.

Market Dynamics


  • Versatility and Superiority of Gelatin in Pharmaceutical Applications
  • Gelatin is an All-Natural Product Fulfilling Pharmaceutical Regulations


  • Increasing Popularity of Veganism
  • Cultural Restrictions Limit the Growth of Pharmaceutical Gelatin in Certain Regions


  • Rising Demand for Pharmaceutical-Grade Gelatin in Emerging Countries
  • Enhancements in the Properties of Gelatin Broaden the Scope of Its Pharmaceutical Applications


  • Increasing Incidences of Animal-Borne Diseases
  • Rising Prices and Poor Availability of Raw Materials

Porter's Five Forces Analysis

Trends in Average Selling Price

Value Chain Analysis

  • Sourcing of Raw Material
  • Collection and Transport of Raw Material
  • Raw Material Preparation and Processing
  • Gelatin Production
  • Distribution to End-users

Ecosystem Map

  • Farming Input
  • Farming
  • Slaughtering
  • Manufacturing
  • Suppliers/Distributors
  • End-Product Manufacturers

Key Markets for Import/Export

  • US
  • China
  • Brazil

Companies Mentioned

  • Aspire Pharmaceuticals
  • Baotou Dongbao Bio-Tech Co. Ltd.
  • Darling Ingredients Inc.
  • Gelco International
  • Geliko LLC
  • Gelita Ag
  • Gelnex Industria E Comercio Ltda
  • Geltech Co. Ltd.
  • Henan Boom Gelatin Co. Ltd.
  • India Gelatine & Chemicals Ltd.
  • Italgelatine S.P.A.
  • Junca Gelatines Sl
  • Kenney & Ross Limited
  • Lapi Gelatine S.P.A
  • Nitta Gelatin Inc.
  • Norland Products, Inc.
  • Tessenderlo Group
  • Trobas Gelatine B.V.
  • Weishardt
  • Xiamen Gelken Gelatin Co. Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/d82tc6

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


Contact Data